You seem to have Javascript disabled. This website needs javascript in order to function properly!
Biomarck is pleased to announce its inclusion on COVID-19 Drug Treatment Trackers:
Milken Institute COVID-19 Treatment and Vaccine Tracker
|
Artis Ventures
About Us
Leadership Team
Scientific Advisory Consultants
Press
Contact
Discovery
About anti-MARCKS
About BIO-11006
Dr. Kenneth Adler
Method of Action
Watch our MOA video
Pipeline
Clinical Trials
ARDS
About ARDS
Method Of Action (MOA) in ARDS
Cancer
Non Small Cell Lung Cancer
Method Of Action (MOA) of Peptide in Cancer
Rare Pediatric Cancers
Investors
Publications
Selected Publications
Full Publication List
DEVELOPING ANTI-MARCKS TECHNOLOGIES
PIPELINE
Group
Created with Sketch.
BIO-11006
Biomarck Pipeline as of April 2020
ARDS
Pre-Clinical
Pre-Clinical
Phase 1
Phase 1
Phase 1
Pre-Clinical
Expanded Access
Phase 2a
Phase 2a
Phase 2a
NSCLC
COPD
Pediatric Cancer
BIO-11006